What questions should I ask my oncologist about locally advanced Melanoma

Questions to Ask Your Oncologist About Locally Advanced Melanoma

Based on the NCCN Guidelines for Patients: Melanoma, here are the most important questions to help you understand your diagnosis and treatment options:

Understanding Your Diagnosis & Staging

1. "Can you explain my specific stage and what 'locally advanced' means for my case?"

   • This helps clarify whether your melanoma is stage 3 (regional spread to lymph nodes or nearby skin) versus other stages, which affects treatment planning.

2. "What tests or biopsies confirmed my diagnosis, and are there any additional tests you recommend?"

   • According to NCCN Guidelines, testing may include skin biopsies, imaging, and potentially BRAF mutation testing (a genetic marker that affects treatment options).

3. "Do I have a BRAF mutation or other biomarkers that would affect my treatment?"

   • This is critical because BRAF mutations open up targeted therapy options like dabrafenib/trametinib, which work differently than immunotherapy.

Treatment Options & Decision-Making

1. "What are my main treatment options, and which do you recommend for my situation?"

   • According to NCCN Guidelines, locally advanced melanoma may be treated with:
     • Surgery (complete excision to remove all disease)
     • Systemic therapy (immunotherapy or targeted therapy)
     • T-VEC/intralesional therapy (injections directly into tumors)
     • Radiation therapy
     • Combinations of these approaches

2. "Will I need surgery, and if so, what does that involve?"

   • Understanding whether your melanoma is "resectable" (can be surgically removed) versus "unresectable/borderline resectable" (difficult or impossible to remove completely) determines your treatment path.

3. "If surgery is recommended, what are the goals—to remove all disease or to reduce the tumor before other treatment?"

   • NCCN Guidelines distinguish between surgery as primary treatment versus "neoadjuvant" surgery (treatment before the main therapy).

Immunotherapy & Systemic Treatment Questions

1. "Am I a candidate for immunotherapy, and how does it work?"

   • Immunotherapy (checkpoint inhibitors like pembrolizumab or nivolumab) helps your immune system fight cancer cells. Understanding how it works and whether you're eligible is essential.

2. "What are the side effects of the treatments you're recommending, and how are they managed?"

   • Different treatments have different side effect profiles. This helps you prepare and know what to expect.

3. "How long will treatment last, and how often will I need appointments?"

   • This affects your work, family, and daily life planning.

Adjuvant (Follow-Up) Treatment

1. "After my main treatment, will I need additional therapy to prevent recurrence?"
   • According to NCCN Guidelines, after surgery with no evidence of disease remaining, you may be offered adjuvant immunotherapy (nivolumab or pembrolizumab) or observation, depending on your specific situation.

Monitoring & Recurrence

1. "How will you monitor me for recurrence, and how often will I need follow-up appointments?"

   • NCCN Guidelines recommend regular skin exams and possibly imaging. Understanding your follow-up plan helps you stay vigilant.

2. "What signs or symptoms should I watch for between appointments?"

   • Learning the ABCDE rule (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving/changing) helps you detect changes early.

Clinical Trials & Second Opinions

1. "Are there clinical trials available for my type of melanoma that I should consider?"

   • Clinical trials may offer access to newer treatments. NCCN Guidelines emphasize that all patients should consider clinical trial options.

2. "Would you recommend a second opinion, or would you be comfortable with me seeking one?"

   • Getting another expert's perspective is standard practice and helps ensure you're receiving optimal care.

Practical & Support Questions

1. "What support services are available—counseling, support groups, financial assistance?"
   • NCCN Guidelines acknowledge that cancer care is stressful. Resources exist to help with emotional, practical, and financial needs.

---

Why These Questions Matter

According to the NCCN Guidelines for Patients: Melanoma, "You have an important role to play in your care. In fact, you're more likely to get the care you want by asking questions and making shared decisions with your care team." Being informed and actively involved in your treatment decisions leads to better outcomes and greater satisfaction with your care.

The key is understanding:

• Your specific stage and what it means
• Which treatment options exist for YOUR situation (not just general options)
• Why your doctor recommends a particular approach
• What to expect during and after treatment

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.